A, Treatment schema. Q, every. *One patient received HiDAC but did not receive pembrolizumab due to ongoing grade 3 diarrhea and was thus replaced on this study. B, ORR among different patient subsets. CRi, CR with incomplete platelet recovery; MLFS, morphologic leukemia-free state; PR, partial remission.